The correlation between cell surface markers and clinical features in choroidal malignant melanomas

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Eye

• Publication date

  1999-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/eye.1999.79PMID 10624422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C-myc oncogene expression in ocular melanomas

  2004cited by this paper
• Letter

  1999cited by this paper
• Simultaneous cell cycle and phenotypic analysis of primary uveal melanoma by flow cytometry

  1998cited by this paper
• DNA index and % S phase fraction in posterior uveal melanoma: A 5 year prospective study of fresh tissue using flow cytometry

  1997cited by this paper
• Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma.

  1996cited by this paper
• C-myc oncogene expression in human melanoma and its relationship with tumour antigenicity.

  1996cited by this paper
• DNA flow cytometry in uveal melanoma: the effect of pre-enucleation irradiation.

  1995cited by this paper
• Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.

  1995cited by this paper
• Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder.

  1995cited by this paper
• Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form.

  1995cited by this paper
• Prognostic value of DNA ploidy as assessed with flow cytometry in uveal melanoma.

  1995cited by this paper
• Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables.

  1995cited by this paper
• Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy.

  1994cited by this paper
• Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.

  1994cited by this paper
• Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.

  1994cited by this paper
• c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle.

  1994cited by this paper
• [DNA flow cytometry of malignant melanoma of the choroid].

  1993cited by this paper
• Deoxyribonucleic acid ploidy studies in choroidal melanomas.

  1993cited by this paper
• Infiltrating lymphocytes and antigen expression in uveal melanoma.

  1992cited by this paper
• DNA PLOIDY STUDIES IN CHOROIDAL MELANOMAS

  year unknowncited by this paper

• Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial–mesenchymal transition

  2018cites this paper
• A novel combinatorial treatment option for metastatic uveal melanoma

  2015cites this paper
• Targeting Bcl-2/Bcl-XL Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts

  2014cites this paper
• A Role for EZH2 in Silencing of IFN-γ Inducible MHC2TA Transcription in Uveal Melanoma1

  2007cites this paper
• Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.

  2003cites this paper
• Adhesion and invasion studies of uveal melanoma.

  2003cites this paper
• Depsipeptide ( FR 901228 ) Inhibits Proliferation and Induces Apoptosis in Primary and Metastatic Human Uveal Melanoma Cell Lines

  2003cites this paper
• p53 Immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroid

  2002cites this paper
• Bcl-2 Expression in Primary Uveal Melanoma

  2001cites this paper
• Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma.

  2001cites this paper
• SUSCEPTIBILITY OF HUMAN WM MELANOMA CELL LINES TO NK AND LAK CYTOTOXICITY AND THEIR RELEVANCE TO THE LEVEL OF MHC CLASS I AND ICAM-1 ANTIGEN EXPRESSION

  2000cites this paper